Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes.
about
The rare intracellular RET mutation p.Ser891Ala in an apparently sporadic medullary thyroid carcinoma: a case report and review of the literatureMultiple endocrine neoplasia type 2: achievements and current challengesSimultaneous medullary and papillary thyroid cancer: a novel entity?Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an updateGenotype-Phenotype Correlation in Patients With Germline Mutations of VHL, RET, SDHB, and SDHD Genes: Thai Experience.Medullary thyroid carcinoma: molecular signaling pathways and emerging therapiesThe modifier role of RET-G691S polymorphism in hereditary medullary thyroid carcinoma: functional characterization and expression/penetrance studies.The optimal range of RET mutations to be tested: European comments to the guidelines of the American Thyroid Association.Pediatric Medullary Thyroid CarcinomaDistribution of RET Mutations and Evaluation of Treatment Approaches in Hereditary Medullary Thyroid Carcinoma in Turkey.A differential diagnosis of inherited endocrine tumors and their tumor counterparts2012 European thyroid association guidelines for genetic testing and its clinical consequences in medullary thyroid cancerIn vitro and in vivo activity of cabozantinib (XL184), an inhibitor of RET, MET, and VEGFR2, in a model of medullary thyroid cancer.Preoperative basal calcitonin and tumor stage correlate with postoperative calcitonin normalization in patients undergoing initial surgical management of medullary thyroid carcinoma.Differences in the transcriptome of medullary thyroid cancer regarding the status and type of RET gene mutations.Hereditary medullary thyroid carcinoma: the management dilemma.Molecular mechanisms of RET receptor-mediated oncogenesis in multiple endocrine neoplasia 2.Association of synchronous medullary and papillary thyroid carcinomas with primary hyperparathyroidism: first case report and literature review.Current Advances in Thyroid Cancer Management. Are We Ready for the Epidemic Rise of Diagnoses?Medullary Thyroid Cancer: Clinical Characteristics and New Insights into Therapeutic Strategies Targeting Tyrosine Kinases.Management of hereditary medullary thyroid carcinoma.Medullary Thyroid Carcinoma: Recent Advances Including MicroRNA Expression.Rare diseases in clinical endocrinology: a taxonomic classification system.Hedgehog signaling in human medullary thyroid carcinoma: a novel signaling pathway.Cabozantinib (XL184) for the treatment of locally advanced or metastatic progressive medullary thyroid cancer.Clinical utility gene card for: multiple endocrine neoplasia type 2.Distribution of RET Mutations in Multiple Endocrine Neoplasia 2 in Denmark 1994-2014: A Nationwide Study.Genetic alterations in medullary thyroid cancer: diagnostic and prognostic markers.Cellular signaling pathway alterations and potential targeted therapies for medullary thyroid carcinoma.Genetic and clinical features of multiple endocrine neoplasia types 1 and 2.Multiple endocrine neoplasia 2 in Cyprus: evidence for a founder effect.Germline ESR2 mutation predisposes to medullary thyroid carcinoma and causes up-regulation of RET expression.Diversity of mutations in the RET proto-oncogene and its oncogenic mechanism in medullary thyroid cancer.Utility of Population-Level DNA Sequence Data in the Diagnosis of Hereditary Endocrine Disease.Guidelines for the management of thyroid cancerMedullary Thyroid Carcinoma With Exon 2 p.L56M RET Variant: Clinical Particular Features in Two Patients
P2860
Q26827963-1F24B752-8D40-4316-990C-1F8F198E3FA9Q27024073-CC09A56B-935F-47BE-88E3-0843DEC6BBC6Q30318389-0D2DB4B9-9AFD-4E2C-A097-7DF63E7C6733Q33587821-3ECC652A-4D35-4628-9A33-10C280882745Q33602864-60EBAFD9-FDD8-4BEF-A32E-B5D2D9944E67Q35038893-9FBE538A-6FAD-4805-8A8A-8CA1B6D86C8CQ35215959-844FE489-63BE-4EB9-AFA0-171BECDC46B9Q36690582-C2740CF8-5312-42A3-AE52-237BE5196D8EQ36715586-BB07D97D-C5D8-4FFC-8F6E-E7355C2A07AEQ36722002-8D70DCD8-F6A8-435A-AE5B-F1F9C7AFE90AQ37023603-57023ADC-F6F8-4A7B-BF67-929C0EE8D09EQ37290956-8A5485E5-F2F0-4547-9245-4907B237CA19Q37403891-F5F96CDB-6C08-4127-B555-0423DA4D253EQ37431034-ED8C8C94-D3C4-47F2-9F0F-36D15B9990AEQ37633558-062C467F-C571-4050-95F8-E069AE362EC5Q37969934-247E071B-E7CC-4770-8508-A15A96B355D1Q38010030-80082C64-805D-430B-9FB1-CEBB27F22A2AQ38216052-3E570EF6-6D98-4797-A911-328BDAF61B5BQ38614394-14598A00-2AB3-4BA8-B585-572E1DE93734Q38683133-11C985EA-2012-402F-B67E-C1696479AE57Q38721033-A7F98124-A22D-4A99-A855-32A8F21B3E73Q38931460-3E0386AA-678B-4D8A-8D08-8B75E35E773DQ39102141-A5DAF4AE-C89C-4D1F-80DC-7FEDE732AB98Q39194433-A9E0995D-ACF3-4A39-9A9A-737B8565BCACQ39374983-F5F95C36-D9AD-446C-B2B0-BD8A219280D2Q39701094-F21AE53B-82C9-449C-8EA1-34F339B05E75Q40491580-845D36BA-1FD2-4951-9F73-21EBC2791715Q40820055-F035B482-705A-4BB8-AC79-8E3C6BDC56FEQ41251561-EAA443E4-93FB-4FC7-9282-490CF87D3636Q41667928-DB5E3E0F-B88A-4581-B377-8AA3C029D43AQ49356194-3BB5DEBA-05FC-4A28-B31F-B27C4DE9594CQ50227566-BA8BE4A5-16C1-4A2C-8F73-277FCA4A43A7Q53368705-22ECCDF0-FD77-4EC7-A3C6-F673A7F4CBBCQ55259915-30B7F4A9-8F89-4210-92C2-7CE0F902F3DEQ56554243-A9C975E2-9557-4476-BA59-DAE215E5BE71Q57652811-061403E8-DB98-4FB6-BF62-BAA834DA6036
P2860
Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Multiple endocrine neoplasia t ...... rent genotypes and phenotypes.
@en
Multiple endocrine neoplasia type 2 syndromes
@nl
type
label
Multiple endocrine neoplasia t ...... rent genotypes and phenotypes.
@en
Multiple endocrine neoplasia type 2 syndromes
@nl
prefLabel
Multiple endocrine neoplasia t ...... rent genotypes and phenotypes.
@en
Multiple endocrine neoplasia type 2 syndromes
@nl
P2093
P50
P356
P1476
Multiple endocrine neoplasia t ...... rent genotypes and phenotypes.
@en
P2093
Aldo Pinchera
Antonello Cappai
Augusto Taccaliti
Barbara Cosci
Carlo Cappelli
Cristina Romei
Efisio Puxeddu
Fabio Bondi
Fabio Orlandi
Furio Pacini
P304
P356
10.1530/EJE-10-0333
P50
P577
2010-06-01T00:00:00Z